Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Kalaris Therapeutics (KLRS)

Annual Return

Over the past 3 years, KLRS has had an average annual return of -63.63%, underperforming the benchmark SPY, which returned +19.31% annual.

Over the past 5 years, KLRS has had an average annual return of -60.55%, underperforming the benchmark SPY, which returned +12.55% annual.

Since Jul 30, 2020, KLRS has had an average annual return of -56.62%, underperforming the benchmark SPY, which returned +16.48% annual.

2026202520242023202220212020
-53.10%-12.12%-38.43%-86.73%-60.36%-66.34%+51.40%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026+4.83%+17.76%-44.69%-4.04%-5.26%-22.22%-2.86%-53.10%
2025-2.42%+4.35%-17.86%-22.46%-53.27%-8.00%-0%+52.17%+41.43%-13.13%+24.42%+35.51%-12.12%
2024+5.97%+2.11%+2.41%+5.39%-5.11%-4.04%+2.46%+5.14%+3.58%+15.09%-40.98%-23.61%-38.43%
2023+12.67%+16.83%-41.63%-12.69%+9.59%-9.83%-3.21%-4.86%-31.31%-30.22%+25.21%-63.78%-86.73%
2022-36.93%+10.30%-24.99%-32.61%-14.96%+0.79%+17.71%+63.61%+5.07%-12.19%+8.39%-31.71%-60.36%
2021-4.87%-0.03%-36.00%+0.99%-0.81%-15.78%-3.05%+0.58%+30.18%-4.19%-27.27%-25.90%-66.34%
2020-1.93%+30.08%-15.10%-3.89%+49.87%-2.95%+51.40%

Drawdown analysis of Kalaris Therapeutics (KLRS)

The maximum drawdown for the KLRS was -99.79%, occurring on Aug 13, 2025. This drawdown has not yet recovered.

The current KLRS drawdown is -99.63%.

Since Jul 30, 2020 KLRS has experienced the following drawdowns:

  • 50% or more: 2 times
  • 40% or more: 2 times
  • 30% or more: 2 times
  • 20% or more: 2 times
  • 10% or more: 2 times
DepthStartTo BottomBottomTo RecoverEndTotal
-99.79%Dec 4, 20201176Aug 13, 2025OngoingOngoingOngoing
-50.70%Aug 11, 202024Sep 15, 202056Dec 3, 202080
-1.93%Jul 30, 20201Jul 31, 20201Aug 3, 20202